Cargando…
Population Pharmacokinetics of Isavuconazole in Subjects with Mild or Moderate Hepatic Impairment
Isavuconazole, administered as the prodrug isavuconazonium sulfate, was recently approved by the U.S. Food and Drug Administration and the European Medicines Agency for the treatment of adults with invasive aspergillosis and mucormycosis. The objective of this analysis was to develop a population ph...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Society for Microbiology
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4862513/ https://www.ncbi.nlm.nih.gov/pubmed/26953193 http://dx.doi.org/10.1128/AAC.02942-15 |